Document Detail


Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure.
MedLine Citation:
PMID:  9822098     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We tested the hypothesis that, in patients with stable heart failure, measuring big endothelin-1 (ET-1) plasma level at rest predicts short-term prognosis better than peak oxygen consumption (VO2max) at exercise. BACKGROUND: Cardiopulmonary exercise testing and evaluation of neurohumoral plasma factors are established tools to estimate survival in patients with heart failure. No data, however, exist comparing the prognostic value of both marker categories simultaneously. METHODS: Two hundred twenty-six heart failure patients were studied in regard to a combined end point of death and prioritization for urgent cardiac transplantation within 1 year follow-up. RESULTS: During the study period 149 patients were without cardiac events (group A), 69 patients died or were urgently transplanted (group B) and 8 patients were alive after a nonurgent heart transplant operation. Norepinephrine (p < 0.0001), atrial natriuretic peptide (p < 0.001), big endothelin plasma levels (p < 0.0001 as well as workload, VO2max and achieved percentage of predicted peak oxygen consumption (pVO2max) (all p < 0.0001) differed significantly between groups A and B. In multivariate stepwise regression analysis, however, only big ET-1 plasma concentration (chi2=74.4, p < 0.0001), New York Heart Association function class (chi2=33.9, p < 0.0001), maximal workload (chi2=7.2, p < 0.01, and plasma atrial natriuretic peptide (ANP) concentration (chi2=4.6, p < 0.05) were independently related to outcome. Peak oxygen consumption or pVO2max did not reach statistical significance in this model. Event-free survival rates were significantly lower in patients with a big ET-1 level of 4.3 fmol/ml or more than with lower big ET-1 levels (p < 0.0001). CONCLUSION: We conclude that in patients with chronic heart failure who are stable on oral therapy measuring big ET-1 and ANP plasma levels may be a valuable noninvasive adjunct to improve the prognostic accuracy of detecting high risk patients compared with exercise testing alone.
Authors:
M Hülsmann; B Stanek; B Frey; B Sturm; D Putz; T Kos; R Berger; W Woloszczuk; D Putz; T Kos; R Berger; W Woloszczuk; G Maurer; R Pacher
Related Documents :
11182188 - Disparate results of ace inhibitor dosage on exercise capacity in heart failure: a reap...
8790948 - Evaluation of heart failure patients: objective parameters to assess functional capacity.
9788828 - Improved exercise tolerance after losartan and enalapril in heart failure: correlation ...
18719758 - Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-...
14660498 - Oxygen-sensing neurons in the central nervous system.
11258638 - Relationship between run times to exhaustion at 90, 100, 120, and 140% of vvo2max and v...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  32     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1998-12-16     Completed Date:  1998-12-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1695-700     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiology, University of Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cardiac Output, Low / blood,  drug therapy,  physiopathology*
Endothelin-1
Endothelins / blood*
Exercise Test / standards*
Female
Heart / physiopathology*
Humans
Lung / physiopathology*
Male
Middle Aged
Multivariate Analysis
Prognosis
Proportional Hazards Models
Protein Precursors / blood*
Risk Assessment
Survival Analysis
Time Factors
Chemical
Reg. No./Substance:
0/Endothelin-1; 0/Endothelins; 0/Protein Precursors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferi...
Next Document:  Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and ...